Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Intestinal bacteria and ulcerative colitis.

J H Cummings1, G T Macfarlane, S Macfarlane

  • 1Department of Molecular and Cellular Pathology, University of Dundee, Ninewells Hospital Medical School, Dundee DD1 9SY, UK. h.cowper@dundee.ac.uk

Current Issues in Intestinal Microbiology
|April 15, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Child abuse and neglect and mental health outcomes in adulthood by ethnicity: Findings from a 40-year longitudinal study in New Zealand/Aotearoa.

Child abuse & neglect·2023
Same author

Plant Poly(ADP-Ribose) Polymerase 1 Is a Potential Mediator of Cross-Talk between the Cajal Body Protein Coilin and Salicylic Acid-Mediated Antiviral Defence.

Viruses·2023
Same author

The feasibility of home monitoring of young people with cystic fibrosis: Results from CLIMB-CF.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2021
Same author

Application of the Theoretical Domains Framework to identify factors that influence hand hygiene compliance in long-term care.

The Journal of hospital infection·2018
Same author

Production of immune response mediators by HT-29 intestinal cell-lines in the presence of Bifidobacterium-treated infant microbiota.

Beneficial microbes·2015
Same author

Body weight, body image and primary postpartum haemorrhage: a review of the literature.

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology·2014

The gut microflora plays a role in ulcerative colitis (UC) inflammation. While antibiotics have shown limited success, probiotics offer a promising approach for managing UC and pouchitis.

Area of Science:

  • Gastroenterology
  • Microbiology
  • Immunology

Background:

  • Intestinal microflora is implicated in ulcerative colitis (UC) initiation and maintenance.
  • UC is thought to result from an abnormal immune response to commensal bacteria in genetically susceptible individuals.
  • UC patients exhibit increased mucosal IgG against normal microflora and altered bacterial populations, with reduced beneficial bacteria.

Purpose of the Study:

  • To review the role of intestinal microflora in ulcerative colitis.
  • To evaluate the efficacy of antibiotics and probiotics in managing UC.
  • To identify areas for future research focusing on the mucosal microflora and its modulation.

Main Methods:

  • Review of evidence from animal models and human studies on ulcerative colitis.

Related Experiment Videos

  • Analysis of antibiotic efficacy in animal models and clinical trials.
  • Examination of studies on probiotic use in UC and pouchitis.

    • Main Results:

    • Antibiotics show protective effects in animal models but have disappointing results in human trials for UC.
    • Probiotics have demonstrated consistent benefits in managing UC and pouchitis in limited studies.
    • The precise bacterial targets, optimal antibiotic timing, duration, and combinations for UC remain unknown.

    Conclusions:

    • Modulating the gut microflora, particularly with probiotics, holds promise for managing ulcerative colitis and pouchitis.
    • Further research is needed on mucosal microflora, its immune interactions, metabolic functions, and modification strategies.
    • Understanding the complex interplay between the gut microbiome and the immune system is crucial for developing effective UC therapies.